First-Line Therapy for Pan-Sensitive Klebsiella UTI

Treatment Selection

The American Urological Association recommends nitrofurantoin, trimethoprim-sulfamethoxazole (TMP-SMX), or fosfomycin as first-line therapy for uncomplicated cystitis, with a treatment duration of 5-7 days 1, 2, 3
For uncomplicated lower UTI, the European Association of Urology suggests choosing first-line options based on local availability and patient factors, with nitrofurantoin preferred due to minimal collateral damage and low resistance rates 1, 2, 3
Trimethoprim-sulfamethoxazole (TMP-SMX) is effective if local resistance is less than 20% 2, 3
Fosfomycin is a single-dose option with minimal resistance 1, 3

The European Urology guidelines recommend empiric parenteral therapy with a third-generation cephalosporin, such as ceftriaxone, until sensitivities are available 4, 5
Amoxicillin plus an aminoglycoside or a second-generation cephalosporin plus an aminoglycoside are also options for empiric parenteral therapy 4, 6
Once pan-sensitivity is confirmed, transition to oral therapy with ciprofloxacin, levofloxacin, or TMP-SMX 4, 5

The FDA advises against using fluoroquinolones as first-line therapy for uncomplicated UTI due to an unfavorable risk-benefit ratio and serious disabling adverse effects 1, 7
Fluoroquinolones cause significant collateral damage to protective vaginal/periurethral microbiota, promoting more rapid UTI recurrence 1, 7
Beta-lactam antibiotics are not recommended as first-line therapy despite pan-sensitivity due to collateral damage effects and promotion of more rapid recurrence of UTI 1, 7

The American Urological Association recommends not treating asymptomatic bacteriuria to avoid increasing the risk of symptomatic infection, bacterial resistance, and healthcare costs 1, 2
Unnecessarily long treatment courses should be avoided, as they are associated with more recurrences due to loss of protective microbiota 1, 2
Fluoroquinolones should not be used if the patient has used them in the last 6 months, as this significantly increases the risk of resistance 4, 6

For catheter-associated UTI, the European Urology guidelines recommend removing or replacing the catheter if possible, then treating with the same principles as complicated UTI 4, 6
For pregnant women or children, amoxicillin-clavulanate becomes an acceptable option given different risk-benefit considerations 3